Navigation Links
Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington
Date:11/9/2007

KIRKLAND, Wash., Nov. 9 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (OTC Bulletin Board: CCYG) announced today that is has received notice of the issuance of a U.S. patent (U.S. Patent No. 7,282,222) for its unique methods and compositions approach to deliver and direct stem cells to target organs in the body.

Using this now-patented technology, exclusively licensed to CellCyte from the US Department of Veterans Affairs, the company is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased and other target organs, such as the heart.

Dr. Ronald Berninger, Chief Scientific Officer of CellCyte Genetics explains, "The goal of CellCyte's stem cell targeting/retention therapies is to enhance the number of cells available for regeneration of damaged tissue, and thereby markedly increase opportunities for healing and restoring organ function. The company's first product in development, CCG-TH30, is designed to target autologous bone-marrow-derived (adult) stem cells to the heart of patients after a heart attack."

"In preclinical models, CCG-TH30 has been shown to increase the retention of stem cells up to as much as 77% in pre-clinical models as compared to conventional methods, which achieve only up to about 6%," Berninger states. "Importantly, CellCyte's product candidate, along with stem cells, can both be delivered intravenously through a patient's circulatory system without an invasive procedure."

Company CEO, President and Chairman, Gary A. Reys emphasizes the importance of the patent's issuance to the company's position. Reys states, "This patented technology is significant, as it has the potential to fill an important missing piece in the field of regenerative medicine, namely, the ability to target and then keep cells in an organ of interest, in this case, the heart. The issuance of a patent for this platform assures
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... London, UK (PRWEB) July 10, 2014 ... inaugural 21st Century Medicine Forum on ‘Commercialising Longevity ... scientists and entrepreneurs to the London Bioscience Innovation ... Biogerontology Research Foundation and Aging Analytics Ltd. The ... and investment in translational research for age-related disease, ...
(Date:7/10/2014)... Terascala, the industry leader in ... a former vice president of product management for Flexera ... of marketing. Terascala’s software when combined with leading compute ... highest performance and most reliable solutions for processing big ... channel expansion and broaden its product portfolio. His leadership ...
(Date:7/10/2014)... Robert Harman, DVM, Founder and CEO of Vet-Stem, Inc., the ... relaunch of his highly informative blog, now named Stem Cells ... are Stem Cells ?” Dr. Harman’s purpose for blogging ... basics of stem cell therapy so that pet owners can ... when considering regenerative medicine. , A veterinarian by trade, Dr. ...
(Date:7/10/2014)... QC (PRWEB) July 10, 2014 EvoDerma ... and convenience. This rejuvenating device now comes with a second ... develops over time. , The new cup is thinner on ... design works to target rough, thin and uneven surfaces on ... firm cup for a stimulating treatment on areas such as ...
Breaking Biology Technology:DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 2Robert Harman, DVM Talks About What Stem Cells are in His Latest Blog Series for Vet-Stem, Inc. 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... Gov. Jim Doyle and the Republican-led Legislature are still ... treat public school districts across Wisconsin. Doyle thinks he ... Republicans believe Doyle abused his veto power and put ... over how to pay for public education appears destined ...
... Madison, Wis. You work hard. You've developed ... recognized within your company. And you just got fired. Or ... bought out. Whatever. The bottom line is that that sweet ... a sudden lost-in-a-dark-woods turn. , ,I'd like to say this ...
... universal presentation tool that isn't universally loved. But Microsoft's PowerPoint ... shouldn't be if its use in distance learning is to ... Horton, a partner in the Denver-based William Horton Consulting. ... sneer, smile and say, `That's nice,'" said Horton, who, with ...
Cached Biology Technology:Before deciding how to pay for K-12 schools, let's determine what to buy 2Before deciding how to pay for K-12 schools, let's determine what to buy 3When doing a good job isn't good enough 2When doing a good job isn't good enough 3Bringing distance learning alive 2
(Date:7/11/2014)... WASH. July 11, 2014 Researchers have ... three-dimensional images. The new technology, called Virtual Finger, ... small structures like neurons and synapses using the ... unique technology makes 3D imaging studies orders of ... at an unprecedented level across many areas of ...
(Date:7/11/2014)... to the hippocampus, the marginal division of the ... What is the impact degree of substance P ... memory function? Yan Yu and his team, College ... using immunofluorescence staining, that substance P receptor, neurokinin ... striatal marginal division of normal rats. Unilateral or ...
(Date:7/11/2014)... , July 11, 2014 Research ... "International Biometrics Technology Market - Industry Analysis Size ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... and crimes has created a need for high level ... used for personnel authentication such as username and passwords, ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... Researchers at Cold Spring Harbor Laboratory (CSHL) announced ... RNAs. At the same time, they reported that their ... pathway for RNA processing in which these and possibly ... part of a multinational project called ENCODE, also provided ...
... U.S. National Science Foundation and the U.S. Implementing Organization ... occasion of the research vessel JOIDES Resolution sailing off ... Honolulu, after a complete transformation to modernize and upgrade ... JOIDES Resolution is the U.S. research vessel for exploring ...
... LAKE CITY As scientists celebrate 2009 as the ... psychology and other fields will gather at the University ... shaped human aggression and violence, from war to domestic ... violence, and how can we use this knowledge to ...
Cached Biology News:CSHL scientists find a new class of small RNAs and define its function 2CSHL scientists find a new class of small RNAs and define its function 3Ocean research officials hail completion of modernization for US scientific ocean drilling vessel 2The Evolution of Human Aggression: Feb. 25-27 conference 2The Evolution of Human Aggression: Feb. 25-27 conference 3The Evolution of Human Aggression: Feb. 25-27 conference 4
Each bottle contains: Bromophenol Blue 0.25% w/v , Xylene Cyanol FF 0.25%, Glycerol solution 30% w/v...
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, Xylene Cyanol, glycerol solution in TE...
Xanthine Oxidase (Bovine Buttermilk). Monospecific by IEP. Some cross reactivity with Xanthine Oxidase of other species and tissues may occur....
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Biology Products: